CLARITY: Medical World Model for Guiding Treatment Decisions by Modeling Context-Aware Disease Trajectories in Latent Space
TLDR
CLARITY is a medical world model that forecasts disease trajectories in latent space, integrating temporal and clinical context for treatment decisions.
Reasoning
The paper introduces a novel approach to medical world modeling by explicitly incorporating temporal and clinical contexts, and linking predictions to treatment decisions, which addresses key limitations of prior work. Its strength lies in the structured latent space and prediction-to-decision framework, but the evaluation is limited to a single dataset (MU-Glioma-Post) and the abstract does not provide details on broader generalization or ablation studies.
Read-first score
Read-first score 43.2, weighted from topical fit, citation, graph, method, reproducibility, and recency signals. Original total remains 41.
Field roles
Rank sensitivity
Stability: volatile; rank range: 383.
Keyword Scores
Deep Analysis
Innovations
- Forecasting disease evolution directly within a structured latent space rather than relying on stochastic diffusion models for visual reconstruction
- Explicit integration of time intervals (temporal context) and patient-specific data (clinical context) to model treatment-conditioned progression as smooth, interpretable trajectories
- Novel prediction-to-decision framework that translates latent rollouts into transparent, actionable treatment recommendations
Methodology
CLARITY is a medical world model that operates in a structured latent space to forecast disease evolution. It incorporates temporal context (time intervals) and clinical context (patient-specific data) to model treatment-conditioned trajectories. The model uses a prediction-to-decision framework to convert latent rollouts into actionable treatment plans, and is evaluated on the MU-Glioma-Post dataset against baselines including MeWM and medical-specific large language models.
Key Results
On the MU-Glioma-Post dataset, CLARITY outperforms the recent MeWM by 12% and significantly surpasses all other medical-specific large language models in treatment planning performance.
Limitations
- Evaluation is limited to a single dataset (MU-Glioma-Post), so generalizability to other cancer types or clinical settings is not established
- The latent space modeling may not fully capture all causal physiological transitions, potentially limiting physiological faithfulness
- The approach requires detailed patient-specific temporal and clinical data, which may not be available in all clinical scenarios